Advanced Search

Study Preview



Study Title and Description

Early withdrawal of calcineurin inhibitor from a sirolimus-based immunosuppression stabilizes fibrosis and the transforming growth factor-β signalling pathway in kidney transplant.



Key Questions Addressed
3 In adult renal transplants, how do immunosuppressive regimens designed to reduce or eliminate exposure to CNI toxicity compare with each other and with full-dose CNI regimens for health outcomes? AND How does the type of induction agent (including when no induction is used) and the use of concurrent immunosuppressive agents affect outcomes of regimens that reduce or eliminate CNI exposure?
  • Comments Comments (
    0
    ) |

Primary Publication Information
  • Comments Comments (
    0
    ) |
TitleData
Title Early withdrawal of calcineurin inhibitor from a sirolimus-based immunosuppression stabilizes fibrosis and the transforming growth factor-β signalling pathway in kidney transplant.
Author Rivelli RF., Gonçalves RT., Leite M., Santos MA., Delgado AG., Cardoso LR., Takiya CM.
Country Faculty of Medicine, Federal University of Rio de Janeiro, CEP 21941-902, Rio de Janeiro, Brazil; Nephrology Service, University Hospital Clementino Fraga Filho, Federal University of Rio de Janeiro, CEP 21941-902, Rio de Janeiro, Brazil.
Year 2015
Numbers Pubmed ID: 25404086
2712 (internal)

Secondary Publication Information
There are currently no secondary publications defined for this study.


Extraction Form: Comparative Effectiveness of Regimens


Results & Comparisons

No Results found.